• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Muhammad Naveed Yasin, Darren Svirskis, Ali Seyfoddin, Ilva Dana Rupenthal
  • Chemistry, Medicine
  • Journal of controlled release : official journal…
  • 2014 (First Publication: 28 December 2014)
  • Efficient drug delivery to the posterior segment of the eye is a challenging task for the formulation scientist. Current treatment of chronic back-of-the-eye conditions requires frequent intravitrealContinue Reading
  • Ali Seyfoddin, Raida Al-Kassas
  • Chemistry, Medicine
  • Drug development and industrial pharmacy
  • 2013 (First Publication: 1 April 2013)
  • The objective of the present investigation was to improve the ocular bioavailability of acyclovir by incorporating it into solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs).Continue Reading
  • Ali Seyfoddin, Alex Hamilton Chan, W.-t. Chen, Ilva Dana Rupenthal, Geoffrey I N Waterhouse, Darren Svirskis
  • Chemistry, Medicine
  • European journal of pharmaceutics and…
  • 2015 (First Publication: 1 August 2015)
  • Corticosteroids such as dexamethasone are first line ophthalmic treatment for non-infectious posterior uveitis. Corticosteroids are often administered via intravitreal injection to treat thisContinue Reading
  • Jingjunjiao Long, Ashveen V. Nand, +4 authors Ali Seyfoddin
  • Chemistry, Medicine
  • International journal of pharmaceutics
  • 2018 (First Publication: 2 July 2018)
  • ABSTRACT Customisation of sustained and controlled release of contraceptives plays a key role in veterinary applications. A biodegradable projectile containing different doses of contraceptiveContinue Reading
  • Yosra Agban, Jiaxin Lian, Sujay Prabakar, Ali Seyfoddin, Ilva Dana Rupenthal
  • Chemistry, Medicine
  • International journal of pharmaceutics
  • 2016 (First Publication: 30 March 2016)
  • Glaucoma is a common progressive eye disorder which remains the second leading cause of blindness worldwide. Current therapy involves frequent administration of eye drops which often results in poorContinue Reading